公司资料
Codexis 股价、新闻与催化剂
- 股票代码:
- CDXS
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.66 USD (-0.60%)
收盘价
最后更新: 2026年8月24日
245M USD
市值
股价为何变动
As of Aug 24, 2026, CDXS closed down 0.60% at $1.66. No new same-company headline was identified in the current news window.
公司概览
业务概览
Codexis is an enzyme-engineering company that serves pharma manufacturing, therapeutics, and bioprocessing needs. Its business is built around using protein engineering to solve industrial and healthcare problems.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Codexis sits in life-sciences tools and biotech infrastructure.
商业模式特征
The company depends on platform adoption, customer relationships, and the monetization of engineered enzymes across markets.
生物医药行业定位
Codexis is a biotech-enabling platform name rather than a drug developer.
未来催化剂
- Codexis’s catalysts are enzyme-engineering partnerships, next-gen biocatalyst demand, and any update that shows the platform is still winning in pharma manufacturing and sequencing workflows. Investors will care about whether recurring platform revenue keeps proving the model works.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。